BioCardia, Inc
Price
FilingsNewest: 8-K, Other eventsOct 1 →Insiders2 insiders bought $138,071 in 19 open-market buys. No sales.→HoldersCitigroup 2.7%CM 2.0%Vanguard 0.8%→PeersClosest companies: TNYA, CLDI, CMPX→
From the filings
Figures
- Revenue
- $0.00last 12 months
- Net income
- −$7.3Mlast 12 months
- Operating cash flow
- −$7.5Mlast 12 months
- Cash and equivalents
- $4.1Mat the last balance sheet
- Shares outstanding
- 15.0M shareson issue